
ENDRA Life Sciences NDRA
€ 3.86
-4.83%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Land |
|
IPO-Jahr |
2017 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
537 K |
Marktkapitalisierung |
$ 2.43 M |
EBITDA (LTM) |
$ -7.08 M |
P/E (LTM) |
-0.38 |
P/S (LTM) |
6.81 |
EPS (LTM) |
-11.77 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 19.02 | 0.21 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 20.15 | -2.3 % | $ 217 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 0.17 | -6.7 % | $ 4.99 M | Nasdaq Capital Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Danaher Corporation
DHR
|
$ 228.92 | -0.76 % | $ 167 B | NYSE,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 66.37 | -1.03 % | $ 25.6 B | Nasdaq Global Select Market,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.53 | 2.0 % | $ 1.94 M | Nasdaq Capital Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 38.9 | -1.04 % | $ 1.08 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.38 | 6.36 % | $ 323 M | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 225.41 | -1.0 % | $ 40.9 B | NYSE,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.56 | -0.33 % | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 26.27 | -0.83 % | $ 794 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 18.84 | -1.21 % | $ 1.01 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 99.74 | -0.18 % | $ 3.93 B | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 6.15 | -0.32 % | $ 557 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 11.76 | -3.84 % | $ 1.49 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.77 | 0.64 % | $ 461 M | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.12 | - | $ 99.5 K | Nasdaq Capital Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.08 | -1.13 % | $ 20 B | NYSE | ||
|
Precipio
PRPO
|
$ 22.98 | -1.84 % | $ 29.8 M | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 7.96 | -0.13 % | $ 472 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
$ 44.97 | -0.77 % | $ 10 B | NYSE | ||
|
Guardant Health
GH
|
$ 102.14 | 1.53 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
RadNet
RDNT
|
$ 71.35 | -0.2 % | $ 5.21 B | Nasdaq Global Select Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 46.3 | 0.02 % | $ 1.86 B | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 131.16 | -1.2 % | $ 20.9 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 199.48 | -1.24 % | $ 10.2 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 579.45 | -0.69 % | $ 221 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.79 | -3.54 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 31.72 | -1.34 % | $ 1.9 B | Nasdaq Global Select Market,SPB | ||
|
Quidel Corporation
QDEL
|
$ 28.56 | -2.53 % | $ 1.2 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 173.53 | -1.12 % | $ 19.3 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 6.8 | 1.19 % | $ 882 M | Nasdaq Global Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market |